PHC Holdings Corporation (PHCCF)
OTCMKTS · Delayed Price · Currency is USD
7.05
0.00 (0.00%)
Sep 19, 2025, 4:00 PM EDT
PHC Holdings Revenue
PHC Holdings had revenue of 83.86B JPY in the quarter ending June 30, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to 360.26B, up 0.70% year-over-year. In the fiscal year ending March 31, 2025, PHC Holdings had annual revenue of 361.59B with 2.17% growth.
Revenue (ttm)
360.26B JPY
Revenue Growth
+0.70%
P/S Ratio
0.34
Revenue / Employee
39.85M JPY
Employees
9,041
Market Cap
857.04M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 361.59B | 7.69B | 2.17% |
Mar 31, 2024 | 353.90B | -2.53B | -0.71% |
Mar 31, 2023 | 356.43B | 15.98B | 4.69% |
Mar 31, 2022 | 340.45B | 34.38B | 11.23% |
Mar 31, 2021 | 306.07B | 33.43B | 12.26% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |